Clinical Trial Update: Chronic Hepatitis C and Insulin Resistance

View source ↗

Summary

A Garvan Institute-sponsored clinical trial examining hepatitis C and insulin resistance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Insulin Resistance

Snippet

Sponsor: Garvan Institute of Medical Research | Conditions: Hepatitis C, Insulin Resistance | Status: COMPLETED